FOR Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Gains 36 SOHOB Q2 2025 Earnings Preferred Dividend Coverage Maintained with Reported EPS of 021 Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress NGNE Q1 2026 Earnings Earnings Miss Estimates as Pipeline Progress Offsets Financial Headwinds HMN Q1 2026 Earnings EPS Surprises to the Upside Stock Slips 17 Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path